Synergy of Fluconazole with Human Monocytes or Monocyte-Derived Macrophages for Killing of Candida Species

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

1991 • 957 citations

Human Mycoses: Drugs and Targets for Emerging Pathogens

1994 • 239 citations

Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo

1986 • 185 citations

The Emerging Fungal Threat

1994 • 182 citations

Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen

1994 • 182 citations

Mechanisms of host defense against Candida species. II. Biochemical basis for the killing of Candida by mononuclear phagocytes.

1991 • 103 citations

Candidacidal Activity of Monocyte-Derived Human Macrophages: Relationship Between Candida Killing and Oxygen Radical Generation by Human Macrophages

1987 • 80 citations

The Relationship of Transferrin and Iron to Serum Inhibition of Candida Albicans**This study was supported in part by Research Training Grant #T1 AM-5266 (O7), NIAMD, National Institutes of Health, Bethesda, Maryland.

1967 • 76 citations

Fluconazole and Other Azoles: Translation of in Vitro Activity to in Vivo and Clinical Efficacy

1990 • 59 citations

Defective Candidacidal Activity of Alveolar Macrophages and Peripheral Blood Monocytes from Patients with Chronic Obstructive Pulmonary Disease

1991 • 41 citations

Macrophage Colony-Stimulating Factor Induction of Enhanced Macrophage Anticryptococcal Activity: Synergy with Fluconazole for Killing

1994 • 39 citations